RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential of RC88 and RC108 Combined with PD-1 Therapy for Advanced Solid Tumors ...Middle East

The partnership focuses on combining novel antibody-drug conjugates RC88 and RC108 with a PD-1 inhibitor sintilimab for enhanced treatment outcomes YANTAI, China, July 9, 2023 /PRNewswire/ -- RemeGen Co., Ltd. ("RemeGen" or "the Company") (HKG: 9995, SHA: 688331), a fully-integrated...

Hence then, the article about remegen and innovent collaborate on clinical trials to evaluate the potential of rc88 and rc108 combined with pd 1 therapy for advanced solid tumors was published today ( Monday 10/07/2023 - 05:36 AM ) and is available on PR Newswire ( Middle East ) The editorial team at PressBee has edited and verified it, and it may have been modified, fully republished, or quoted. You can read and follow the updates of this news or article from its original source.

Read More Details
Finally We wish PressBee provided you with enough information of ( RemeGen and Innovent Collaborate on Clinical Trials to Evaluate the Potential of RC88 and RC108 Combined with PD-1 Therapy for Advanced Solid Tumors )

Also on site :

• Trump administration, MAGA allies spread misinformation on Pretti killing
• 2000s Post-Hardcore Band Announces Update on 'Last Ever' Show in Brooklyn Venue
• Coach Outlet Has a 'Gorgeous' Cherry Print Shoulder Bag for 50% Off, and It's the Perfect Valentine's Day Accessory